Clinical Trial Update: Abraxane/Bevacizumab [Phase 2]

View source ↗

Summary

A Phase 2 trial of Abraxane (nab-paclitaxel) in combination with Bevacizumab for ovarian cancer and peritoneal cancer was terminated, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Ovarian Cancer, Peritoneal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2013-05-16